biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by IMBROKE2on Jan 10, 2013 12:37pm

145 Views

Post# 20820907

RE: RE: RE: Where's our friend, IMBROKE2 ??

Having an opinion contrary to yours does not make it negative. You ever watch that movie Wall Street? Gekko has a great line about money being transferred from one perception to another. Its a zero sum game, somebody wins and somebody loses.

I have a different perception than you and I'm called negative and bashing. Oh well, thats your perception.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!